Welcome to Xi’an Good Doctor Medical Science and Technology Co., Ltd.website ！
Internet Drug Information Service Qualification Certificate: (Shaanxi)-Non-Operating -2023-0143
Thermal Chemotherapy for Tumors - Current Status and Prospects
Drug treatment for tumors, commonly known as chemotherapy, is currently one of the main methods for treating tumors. With the increasing incidence of malignant tumors, research in related fields is very active worldwide. The emergence of new drugs and the standardization and improvement of chemotherapy regimens have led to a certain degree of improvement in the survival rate and survival time of cancer patients.
2022-08-26
Clinical Analysis of Malignant Chest and Abdominal Cavity Hyperthermic Intraperitoneal Chemotherapy
Malignant pleural and abdominal effusion is one of the common clinical manifestations and serious complications of malignant tumors. Any malignant tumor can cause malignant pleural and abdominal effusion when it invades the thoracic or abdominal cavity. The treatment of malignant pleural and abdominal effusion can be divided into systemic and local treatment methods. For malignant tumors that are sensitive or relatively sensitive to chemotherapy, systemic chemotherapy can lead to malignant pleural effusion.
2022-08-26
In the past two years, the use of constant temperature circulating perfusion for intraperitoneal and venous double-route hyperthermic chemotherapy has achieved satisfactory results in preventing and treating intraperitoneal metastatic cancer, which cannot be achieved by non-circulating hyperthermic perfusion chemotherapy. This article analyzes and compares the mechanisms, feasibility, treatment methods, and efficacy of intraperitoneal circulating and non-circulating hyperthermic perfusion chemotherapy based on clinical observations and literature reports.
2022-08-26
Discuss the efficacy of intraperitoneal hyperthermic chemotherapy after surgery for gastrointestinal malignancies. Method: Select 60 patients with stage II to IV gastrointestinal malignancies after surgery, with 32 cases as the treatment group receiving intraperitoneal hyperthermic chemotherapy + intravenous chemotherapy, and 28 cases as the control group receiving conventional intravenous chemotherapy. Results: The intraperitoneal recurrence rate and metastasis rate in the treatment group were significantly lower than those in the control group (P
2022-08-26
Clinical analysis of 110 cases of gastric cancer peritoneal carcinoma treated with tumor cell reduction surgery combined with intraperitoneal hyperthermic chemotherapy.
2022-08-26
Expert Consensus on Tumor Cell Reduction Surgery Combined with Intraperitoneal Hyperthermic Chemotherapy for Pseudomyxoma Peritonei
2022-08-26
Safety Experimental Study of Intraperitoneal Circulation Hyperthermic Perfusion Chemotherapy - Liu Wenchao 2012 (Li Wei) Safety Experimental Study of Intraperitoneal Circulation Hyperthermic Perfusion Chemotherapy - Liu Wenchao 2012 (Li Wei) Safety Experimental Study of Intraperitoneal Circulation Hyperthermic Perfusion Chemotherapy - Liu Wenchao 2012 (Li Wei)
2022-08-26
Expert consensus on cytoreductive surgery combined with intraperitoneal hyperthermic chemotherapy for peritoneal surface tumors
2022-08-26
A Controlled Study of Intracavitary Constant Temperature Circulating Thermal Perfusion Chemotherapy for Malignant Pleural Effusion - Wang Liufei 2010 (Li Wei)
2022-08-26
Objective: To explore the efficacy of continuous circulating hyperthermic intraperitoneal chemotherapy (HIPEC) at a temperature of 42-43°C for malignant ascites. Method: 45 patients with malignant ascites were randomly divided into two groups. The observation group consisted of 22 patients who underwent conventional puncture to establish a double-channel circulation, first performing peritoneal lavage to replace the intraperitoneal perfusion fluid, and finally maintaining 2500-3500 ml. The continuous circulation at a temperature of 42-43°C began 3-5 minutes later.
2022-08-26
· China Good Doctor ·
· Good friends of human beings ·
Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China
Copyright Xi'an Good Doctor Medical Technology Co., Ltd.
Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143